๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Oral Squamous Cell Carcinoma
Clinical trial register · China

Oral Squamous Cell Carcinoma Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 3 Guangzhou 3 Changsha 2 Hangzhou 1 Shenzhen 1
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai3 Guangzhou3 Changsha2 Hangzhou1 Shenzhen1
All 15 locations
Target enrolment
to

Oral Squamous Cell Carcinoma trials in China

10 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Neoadjuvant Presurgical Becotatug Vedotin (MRG003) Plus Pucotenlimab (HX008) in Oral Cavity Squamous Cell Carcinoma
NCT07766889Oral Squamous Cell Carcinoma, Head and Neck Cancer, Locally Advanced Head and Neck Cancer, Neoadjuvant Therapy
Sun Yat-sen University
Phase 2
32
Guangzhou
2026-09-01
Recruiting
Neoadjuvant Immunochemotherapy for LAOSCC
NCT06258811Oral Squamous Cell Carcinoma, Locally Advanced Head and Neck Carcinoma
Lai-ping Zhong
Phase 3
134
Shanghai
2024-02-20
Recruiting
Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell Carcinoma
NCT05798793Oral Squamous Cell Carcinoma
Hospital of Stomatology, Wuhan University
Phase 3
309
Shenzhen, Wuhan, Changsha
2023-11-21
Active, closed
Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT)
NCT06009861Oral Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma
Peking University Hospital of Stomatology
Phase 2
110
Beijing, Baoding, Tangshan, Harbin, Chifeng, Hohhot, Changchun, Shenyang
2023-06-27
Recruiting
TPExtreme Induced Chemotherapy Followed by Surgery and Radiotherapy in the Oral Carcinoma.
NCT05872880Oral Squamous Cell Carcinoma, Locally Advanced Head and Neck Squamous Cell Carcinoma
Xiangya Hospital of Central South University
Observational
124
Changsha
2022-04-01
Recruiting
Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC
NCT05125055Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1, Chemotherapy
Shanghai Jiao Tong University School of Medicine
Phase 2/3
80
Shanghai
2021-10-01
Recruiting
Neoadjuvant Sintilimab Combined With Reduction of Cycles of Chemotherapy in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma (OOC-002)
NCT05098119Oral Cavity Squamous Cell Carcinoma, Oral Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
43
Guangzhou
2021-09-16
Recruiting
Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients
NCT05069857Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1, Anti-VEGFR
Shanghai Jiao Tong University School of Medicine
Phase 2
46
Shanghai
2021-09-01
Active, closed
Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma
NCT04718415Oral Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
51
Guangzhou, Guanzhou
2021-01-23
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/oral-squamous-cell-carcinoma

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies listing the condition Oral Squamous Cell Carcinoma.

How many Oral Squamous Cell Carcinoma trials are recruiting in China?

7 of the 10 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 1 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Oral Squamous Cell Carcinoma), 10 studies
PhaseStudiesRecruitingShare
Phase 26360%
Phase 32220%
Observational1110%
Phase 2/31110%

Most active sponsors

Lead sponsors with the most studies (Oral Squamous Cell Carcinoma)
Lead sponsorStudiesRecruiting
Shanghai Jiao Tong University School of Medicine22
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University21
Hospital of Stomatology, Wuhan University11
Lai-ping Zhong11
Peking University Hospital of Stomatology10
Sun Yat-sen University10
Weijia Fang, MD11
Xiangya Hospital of Central South University11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.